Human Metabolome Technologies (TSE:6090) Other Current Assets: 円37.6 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6090 Human Metabolome Technologies Inc TSE:6090
59 GF Score
Price 円591.00
GF Value 円531.46
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Human Metabolome Technologies Other Current Assets?

Human Metabolome Technologies TSE:6090 -1.34% 59 Other Current Assets is 円37.6 Mil as of Dec. 2025. GuruFocus rates TSE:6090 with a GF Score™ of 59/100 and a GF Value™ of 円531.46 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Human Metabolome Technologies's other current assets for the quarter that ended in Dec. 2025 was 円37.6 Mil.

Human Metabolome Technologies's quarterly other current assets declined from Jun. 2025 (円80.1 Mil) to Sep. 2025 (円42.9 Mil) and declined from Sep. 2025 (円42.9 Mil) to Dec. 2025 (円37.6Mil).

Human Metabolome Technologies's annual other current assets declined from Jun. 2022 (円35.7 Mil) to Jun. 2023 (円35.5 Mil) increased from Jun. 2023 (円35.5 Mil) to Jun. 2024 (円42.0 Mil).


Human Metabolome Technologies Other Current Assets Related Terms


Human Metabolome Technologies Other Current Assets Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies Other Current Assets Chart

Human Metabolome Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.69 28.41 35.71 35.47 41.97

Human Metabolome Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.48 80.06 42.93 37.65 31.24
TSE:6090
59GF Score
Human Metabolome Technologies Inc TSE:6090
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Human Metabolome Technologies Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of 円37.6 Mil mean?
Human Metabolome Technologies (TSE:6090) has a Other Current Assets of 円37.6 Mil as of Dec. 2025. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Human Metabolome Technologies.
Is Human Metabolome Technologies' Other Current Assets too high?
Human Metabolome Technologies' current Other Current Assets is 円37.6 Mil. Overall, Human Metabolome Technologies has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' Other Current Assets compare to TMO and DHR?
Human Metabolome Technologies' Other Current Assets of 円37.6 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Medical Diagnostics & Research company?
A good Other Current Assets depends on the Medical Diagnostics & Research industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Human Metabolome Technologies. Human Metabolome Technologies's current Other Current Assets is 円37.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Overvalued. The stock's GF Value™ is 円531.46, compared to a current price of 円591.00 — trading 11.2% above its estimated fair value. The current Other Current Assets is 円37.6 Mil. Human Metabolome Technologies' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Other Current Assets is 円37.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be overvalued. The current stock price of 円591.00 is trading 11.2% above its estimated GF Value™ of 円531.46. GuruFocus considers Human Metabolome Technologies to be Modestly Overvalued.

Key valuation signals for TSE:6090:

  • Other Current Assets: 円37.6 Mil
  • GF Value™: 円531.46 vs. price of 円591.00 (11.2% above fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Human Metabolome Technologies Business Description

Address Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.
59GF Score

Get the complete analysis for TSE:6090

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円591.00
Price
円531.46
GF Value